Catalyst Edge · Scanner · Tickers · GCAND
CATALYST DOSSIER · UPDATED 2026-09-22

$GCAND

biotech · convergence -10 · conviction AVOID
Convergence Score
-10
Conviction
AVOID
Signals Firing
7
Quick tools:🃏 Swipe deck🎯 Today verdict

Price & Live Quote

Loading live quote & chart…

Practice trade tools

Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.

Paper trade unavailable: missing risk-bounded frame

Reference only. Not financial advice. No brokerage order is placed.

Why $GCAND?

GCAND -10 AVOID biotech

Quantitative

  • Net Income (CY2026Q2): $611.4K (+256.4% YoY)

Catalysts

  • Multi-spoke convergence: 7 convergent signals fired: xbrl_ni, auto_macro_credit_spreads, auto_macro_crypto_fear_greed, auto_macro_edgar_fts, auto_macro_eia_petroleum

Risks

  • Position-sizing discipline: Conviction AVOID (-10 score) — size accordingly; no specific catalyst-fade risk flagged

Bear case

  • Multiple compression: If breadth deteriorates, biotech-wide multiples re-rate lower regardless of pick-specific thesis

Sympathy basket (cerebro)

  • REZI via consumer r=+0.91 sympathetic (score 33)
  • NXXT via consumer r=+0.91 sympathetic (score 25)
  • ATKR via tech r=+0.80 sympathetic (score 29)
  • DOCU via tech r=+0.80 sympathetic (score 28)
  • NFE via utilities r=+0.77 sympathetic (score 61)
  • EVRG via utilities r=+0.77 sympathetic (score 33)

Signals Firing

xbrl_niauto_macro_credit_spreadsauto_macro_crypto_fear_greedauto_macro_edgar_ftsauto_macro_eia_petroleumauto_macro_ofac_sanctionsauto_macro_term_premium
Each tag is a spoke that flagged this ticker today. Weights tuned weekly against published outcomes.

Recent SEC Filings

Sympathy Basket

Tickers Catalyst Edge tracks as moving with this name. Cross-correlation derived from sector + score-cohort proximity.

Earnings Catalyst

No recent earnings event.

Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks and its losses — see the trust report and methodology. Not financial advice. Confirm independently before trading.

You came here for GCAND. You found it after it moved, the same way everyone else did.

$99 once — every ticker on this site ranked before the open.

Tier 1 setups touched +2% intraday 49.2% of the time across 329 tracked calls. Baseline for everything else: 40.7%. That is a +8.5 point edge, measured from the NEXT OPEN — the first price you could actually pay, not the prior close. We publish the misses too: https://catalystedgescanner.com/trust/

  1. Click Become a Founding Member below.
  2. Pay $99 once — not monthly, not ever again.
  3. You keep every future release at that price. Tomorrow's ranked list lands at 3:30 AM ET, before the open.

29 of 30 founding seats left. The price goes up when they are gone.

Become a Founding Member — $99 once

One payment. Lifetime access. The free daily picks stay free — this is for people who want the full console. Not buying today? Get tomorrow's ranked list free →